Novo Nordisk AS (XBUL:NOV) Other Stockholders Equity : лв0 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Novo Nordisk AS Other Stockholders Equity?

Novo Nordisk AS's Other Stockholders Equity for the quarter that ended in Sep. 2024 was лв0 Mil.

Novo Nordisk AS's quarterly Other Stockholders Equity declined from Mar. 2024 (лв0 Mil) to Jun. 2024 (лв-0 Mil) but then increased from Jun. 2024 (лв-0 Mil) to Sep. 2024 (лв0 Mil).

Novo Nordisk AS's annual Other Stockholders Equity increased from Dec. 2021 (лв-0 Mil) to Dec. 2022 (лв0 Mil) but then stayed the same from Dec. 2022 (лв0 Mil) to Dec. 2023 (лв0 Mil).

Novo Nordisk AS Other Stockholders Equity Historical Data

The historical data trend for Novo Nordisk AS's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk AS Other Stockholders Equity Chart

Novo Nordisk AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

Novo Nordisk AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	-	-	-

Novo Nordisk AS Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Novo Nordisk AS Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Novo Nordisk AS's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (XBUL:NOV) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

NONOF:USA NVO:USA NOVOB:Mexico NVO:Mexico 0TDD:UK NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany N1VO34:Brazil NNO2:Austria

Address

Novo Alle 1, Bagsvaerd, DNK, 2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.